SiNatur GmbH , Martinsried , Germany.
Department of Clinical Pharmacology, Toxicology and Psychopharmacology, Carol Davila University of Medicine and Pharmacy , Bucharest , Romania.
Front Endocrinol (Lausanne). 2015 Jan 23;5:233. doi: 10.3389/fendo.2014.00233. eCollection 2014.
The Na(+)/K(+)-ATPase is a membrane ion-transporter protein, specifically inhibited by digitalis glycosides used in cardiac therapy. The existence in mammals of some endogenous digitalis-like factors (EDLFs) as presumed ATPase ligands is generally accepted. But the chemical structure of these factors remained elusive because no weighable amounts of pure EDLFs have been isolated. Recent high-resolution crystal structure data of Na(+)/K(+)-ATPase have located the hydrophobic binding pocket of the steroid glycoside ouabain. It remained uncertain if the EDLF are targeting this steroid-receptor or another specific binding site(s). Our recently disclosed spherical oligo-silicic acids (SOSA) fulfill the main criteria to be identified with the presumed EDL factors. SOSA was found as a very potent inhibitor of the Na(+)/K(+)-ATPase, Ca(2+)-ATPase, H(+)/K(+)-ATPase, and of K-dp-ATPase, with IC50 values between 0.2 and 0.5 μg/mL. These findings are even more astonishing while so far, neither monosilicic acid nor its poly-condensed forms have been remarked biologically active. With the diameter ϕ between 1 and 3 nm, SOSA still belong to molecular species definitely smaller than silica nano-particles with ϕ > 5 nm. In SOSA molecules, almost all Si-OH bonds are displayed on the external shell, which facilitates the binding to hydrophilic ATPase domains. SOSA is stable for long term in solution but is sensitive to freeze-drying, which could explain the failure of countless attempts to isolate pure EDLF. There is a strong resemblance between SOSA and vanadates, the previously known general inhibitors of P-type ATPases. SOSA may be generated endogenously by spherical oligomerization of the ubiquitously present monosilicic acid in animal fluids. The structure of SOSA is sensitive to the concentration of Na(+), K(+), Ca(2+), Mg(2+), and other ions suggesting a presumably archaic mechanism for the regulation of the ATPase pumps.
钠钾-ATP 酶是一种膜离子转运蛋白,特别容易被心脏治疗中使用的洋地黄糖苷类药物抑制。哺乳动物中存在一些内源性洋地黄样因子(EDLFs)作为假定的 ATP 酶配体,这一点已被普遍接受。但是,这些因子的化学结构仍然难以捉摸,因为没有可称重的纯 EDLF 被分离出来。最近,钠钾-ATP 酶的高分辨率晶体结构数据确定了甾体糖苷哇巴因的疏水性结合口袋。目前还不确定 EDLF 是否针对这种甾体受体或其他特定的结合位点。我们最近披露的球形寡硅酸(SOSA)符合被认为是内源性 EDL 因子的主要标准。SOSA 被发现是一种非常有效的钠钾-ATP 酶、钙-ATP 酶、H+/K+-ATP 酶和 K-dp-ATP 酶抑制剂,IC50 值在 0.2 到 0.5μg/mL 之间。这些发现更加令人惊讶,因为迄今为止,单硅酸及其多缩合形式都没有被认为具有生物活性。SOSA 的直径ϕ在 1 到 3nm 之间,仍然属于分子种类,明显小于ϕ>5nm 的硅纳米颗粒。在 SOSA 分子中,几乎所有的 Si-OH 键都显示在外壳上,这有利于与亲水性 ATP 酶结构域结合。SOSA 在溶液中能长期稳定存在,但对冻干敏感,这可能解释了无数次试图分离纯 EDLF 失败的原因。SOSA 与钒酸盐之间存在很强的相似性,钒酸盐是先前已知的 P 型 ATP 酶的通用抑制剂。SOSA 可能是由动物体液中普遍存在的单硅酸通过球形寡聚化而内源性产生的。SOSA 的结构对 Na+、K+、Ca2+、Mg2+和其他离子的浓度敏感,这表明其可能是一种古老的调节 ATP 酶泵的机制。